Moreover, inhibition of RPE inflammation with Ruxolitinib, a JAK1/2 inhibitor, mitigated the severity of the aggressive, early-onset retina degeneration phenotype observed in Mertk knock out mice.

Show thread
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.